Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibitors of cytochrome P450 (CYP) 1B1
Raphaël Dutour, Donald Poirier
European Journal of Medicinal Chemistry (2017) Vol. 135, pp. 296-306
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Cytochrome P450 Enzymes and Drug Metabolism in Humans
Mingzhe Zhao, Jingsong Ma, Mo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12808-12808
Open Access | Times Cited: 506
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 89
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
Christos Tziotzios, Christos Petridis, Nick Dand, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 104
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes
Yurong Song, Chenxi Li, Guangzhi Liu, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 5, pp. 585-601
Closed Access | Times Cited: 66
Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances
Emilio Mateev, Maya Georgieva, Alexander Zlatkov
Journal of Pharmacy & Pharmaceutical Sciences (2022) Vol. 25, pp. 24-40
Open Access | Times Cited: 58
Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes
Yeo‐Jung Kwon, Sangyun Shin, Young‐Jin Chun
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 63-83
Closed Access | Times Cited: 55
Flavonoids as CYP3A4 Inhibitors In Vitro
Martin Kondža, Ivica Brizić, Stela Jokić
Biomedicines (2024) Vol. 12, Iss. 3, pp. 644-644
Open Access | Times Cited: 5
Pinocembrin alleviates renal ischemia–reperfusion injury/unilateral ureteral obstruction (UUO)‐generated renal fibrosis by targeting the CYP1B1/ROS/MAPK axis
Banghua Zhang, Hui Chen, Rui Yang, et al.
FEBS Journal (2025)
Open Access
Enhanced Photoredox Activity in Nitrogen‐Doped Carbon Nitride for Heterogeneous Nitrogen and Oxygen Radical Reactions
Lan Qin, Huan Liu, Wei Yi, et al.
Advanced Science (2025)
Open Access
Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors
Zbigniew Dutkiewicz, Renata Mikstacka
Bioinorganic Chemistry and Applications (2018) Vol. 2018, pp. 1-21
Open Access | Times Cited: 53
Pesticides diazinon and diuron increase glutathione levels and affect multixenobiotic resistance activity and biomarker responses in zebrafish (Danio rerio) embryos and larvae
Mirna Velki, Carina Lackmann, Alejandro Barranco, et al.
Environmental Sciences Europe (2019) Vol. 31, Iss. 1
Open Access | Times Cited: 52
Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it
Himanshu Verma, Malkeet Singh Bahia, Shalki Choudhary, et al.
Drug Metabolism Reviews (2019) Vol. 51, Iss. 2, pp. 196-223
Closed Access | Times Cited: 47
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
Ying Wang, Xiaomei He, Chunshi Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112235-112235
Closed Access | Times Cited: 40
Flavonoids As CYP3A4 Inhibitors In Vitro
Martin Kondža, Ivica Brizić, Stela Jokić
(2024)
Open Access | Times Cited: 3
Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer
Suzanne J. Bakewell, Isabel Conde, Yassi Fallah, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2647-2647
Open Access | Times Cited: 30
CYP1B1 as a therapeutic target in cardio-oncology
Alexa N. Carrera, Marianne Grant, Beshay N. Zordoky
Clinical Science (2020) Vol. 134, Iss. 21, pp. 2897-2927
Open Access | Times Cited: 30
Myostatin: a multifunctional role in human female reproduction and fertility – a short review
Sijia Wang, Lanlan Fang, Luping Cong, et al.
Reproductive Biology and Endocrinology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy
Ragini Singh, Avadhesh Avadhesh, Gaurav Sharma, et al.
Antioxidants and Redox Signaling (2022) Vol. 38, Iss. 10-12, pp. 853-876
Closed Access | Times Cited: 17
Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors
Jinyun Dong, Zengtao Wang, Jiahua Cui, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111938-111938
Closed Access | Times Cited: 29
Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity
Raphaël Dutour, Jenny Roy, Francisco Cortés‐Benítez, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9229-9245
Closed Access | Times Cited: 28
Anticancer Triazenes: from Bioprecursors to Hybrid Molecules
Ana Paula Francisco, Eduarda Mendes, Ana Rita Santos, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 14, pp. 1623-1642
Closed Access | Times Cited: 28
Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors
Jinyun Dong, G. Huang, Qing Cui, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112895-112895
Closed Access | Times Cited: 25
Scaffold hopping for designing of potent and selective CYP1B1 inhibitors to overcome docetaxel resistance: synthesis and evaluation
Baddipadige Raju, Gera Narendra, Himanshu Verma, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 2
Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1
Baddipadige Raju, Himanshu Verma, Gera Narendra, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 7975-7990
Closed Access | Times Cited: 19
New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top